Anti-Fibrotic Drug Development Summit (AFDD)

Anti-Fibrotic Drug Development Summit (AFDD) is organized by Hanson Wade and would be held during Nov 13 - 14, 2017 at Hyatt Regency Boston, Boston, Massachusetts, United States of America.

Course Descriprtion :
This Course will solve the challenges drug developers face when translating fibrotic mechanisms into clinically effective therapeutics. This unique summit will be an opportunity for drug developers focused on organ-specific indications to participate in a crossdisciplinary, multi-organ discussion in order to gain new insights into their anti-fibrotic drug development research.

Conference Objectives :
Attending this comprehensive forum will enable you to:
• Deepen your understanding on cross-organ fibrotic mechanisms which are driving pathology changes in humans.
• Develop more reliable in vivo models which recapitulate human fibrosis and effectively translate into clinical development.
• Identify reliable biomarkers to improve clinical trial design and quickly determine the efficacy of your compound.

Prices :
Register by August 18 to save $300: USD 2399,
Register by September 8 to save $200: USD 2499,
Register by October 6 to save $100: USD 2599,
Standard Rate: USD 2699.

Speakers :
Ray Jupp (UCB), Richard Marshall (GSK), Lisa Hazelwood (AbbVie), Peter Blume-Jensen (Xtuit Pharmaceuticals), Alexey Lugovskoy (Morphic Therapeutics), Seth Porter (FibroGen)

Additional details will be posted as soon as they are available.